Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 871 results for "sanofi"

Sanofi India banks on Rajaram's FMCG expertise
Money Today

Sanofi appoints new clinical research director

Song Yun-jeong Sanofi, a global healthcare leader, has appointed Song Yun-jeong, a former clinical science team leader at the Samsung Institute of Advanced Technology (SIAT), as clinical research director of its Asia Pacific Therapeutic Strategic ... FirstWord Pharma, 16 hours ago
[x]  

430 images for sanofi

Bio Spectrum Asia, 1 day ago
APN News, 1 week ago
Drug Discovery and Development, 15 hours ago
Medical Plastics News, 1 week ago
Townsville Bulletin, 1 week ago
Livemint.com, 1 week ago
I Stock Analyst, 1 day ago
Site Selection Magazine, 5 days ago
Business Today India, 5 days ago
Moneycontrol.com, 1 week ago
Livemint.com

SANOFI : Glenmark Pharmaceuticals through its Swiss Subsidiary receives USD 5 Mn. as milestone fee payment from Sanofi

04/22/2014 | 08:13am US/Eastern Recommend: 0 Glenmark has received from Sanofi already USD 50 Mn as an upfront payment in FY2011-12. Hence, the total amount received by Glenmark from Sanofi for its first in class VLA-2 monoclonal ...
 4 Traders20 hours ago GLENMARK PHARMACEUTICALS : Gets $5 million from sanofi  4 Traders5 days ago Glenmark gets USD 5 million payment from Sanofi  Money Control1 week ago Glenmark receives $5 m milestone payment from Sanofi  Business Line1 week ago
[x]  
Business Line

Glenmark Shares hit on loss of Tarka patent appeal

Glenmark shares fell as much as 5 per cent today after it announced that it has lost an appeal against Sanofi-Aventis SA and Abbott Lab. The global drugmakers had sought to halt Glenmark's sales of a generic version of their hypertension medicine ...
 NDTV Profit23 hours ago Pharma in focus, Sesa Sterlite falls 3%; Sensex, Nifty flat  Money Control1 day ago Sanofi takes Glenmark to court  The Telegraph1 month ago Patent suit to keep Glenmark in focus  Business Line1 month ago
[x]  

Aastrom buys Sanofi unit

Aastrom Biosciences ( ASTM +30.1% ) acquires Sanofi's Cell Therapy and Regenerative Medicine business for $6.5M. Current revenue for the business is $44M driven by Carticel (autologous cultured chondrocytes), Epicel (cultured epidermal autografts) ...
 Seeking Alpha1 day ago Aastrom Biosciences To Buy Sanofi's CTRM Business For $6.5 Mln - Quick Facts  RTTNews.com1 day ago Aastrom to Acquire Sanofi's CTRM Business  Contract Pharma1 day ago Aastrom Biosciences, Inc. Bags Sanofi (France)'s Cell Therapy And Regenerative Medicine Business For $6.5 Million Cash  BioSpace1 day ago
[x]  

Sanofi Pasteur MSD Welcomes European Immunization Week 2014

/PRNewswire/ -- European vaccine leader hosts events across the region to help raise awareness of immunization throughout life Sanofi Pasteur MSD welcomes the World Health Organization's European Immunization Week 2014 (EIW 2014) with a ...
 ADVFN India1 day ago
[x]  

Stocks in news: TCS, Sanofi, Jubilant FoodWorks, Crompton

TCS | IndusInd Bank | Mindtree | Sanofi | Gujarat Pipavav Port | United Spirits | Crompton Greaves | Wipro | AstraZeneca Pharma | Reliance Power | ILFS Transportation | IOC | Jubilant FoodWorks and DCB Bank are stocks, which are in the news today.
 Money Control1 week ago
Business Insights

Board meeting of Sanofi- Aventis Pakistan Limited to be held on April 23, 2014

Karachi: Sanofi- Aventis Pakistan Limited has informed Karachi Stock Exchange that board meeting of the company will be held on April 23, 2014 at Karachi. The agenda of the meeting is consideration of quarterly accounts for the period ended March ...
 Business Insights1 week ago Sanofi India's AGM on April 29, 2014  Money Control3 weeks ago Sanofi India to hold AGM  Business Standard3 weeks ago Sanofi India fixes book closure for final dividend AGM  Money Control1 month ago
Money Control

Buy Sanofi India; target of Rs 2890: Firstcall Research

Brokerage house Firstcall Research is bullish on Sanofi India and has recommended buy rating on the stock with a target price of Rs 2890 in its research report dated March 07, 2014.
 Money Control1 month ago Sanofi India rallies over 5% as Q4 net profit surges two-fold  Economic Times1 month ago Sanofi releases good Q4 nos, recommends solid dividend  Money Control1 month ago Volumes jump at Sanofi India counter  Business Standard2 months ago
Money Control

Sanofi India firms up after strong Q4 earnings

after net profit surged 106.92% to Rs 92.70 crore on 15.49% increase in total income from operations to Rs 488.30 crore in Q4 December 2013 over Q4 December 2012. The company announced the results after market hours on Tuesday, 25 February 2014. Meanwhile, ...
 Business Standard1 month ago Sanofi India surges 5% as net profit doubles in Q4CY13  Money Control1 month ago Sanofi India Q4 net surges two-fold at Rs 93 cr  Business Standard1 month ago

Pre-Markets: Nifty likely to test 6,350

Watch out for Sanofi India, Manappuram Finance, Tata Power and AstraZeneca Pharma SI Reporter | Mumbai March 6, 2014 Last Updated at 08:38 IST Following positive global trends, the markets are likely to open higher with the Nifty testing the 6,350 levels in ...
 Business Standard1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sanofi
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less